hat
Kri Sibutramine hcl poud te pou kont li retire nan mache Etazini an pa manifaktirè a nan mwa Oktòb, 2010 an nan klinik done jijman ki endike yon anpil risk atak kè ak kriz tansyon. Kantite dòz enfòmasyon sa a nan la pou lè a dwòg te disponib nan peyi Etazini.
eng
Raw Sibutramine hcl powder was voluntarily withdrawn from the US market by the manufacturer in October, 2010 due to clinical trial data indicating an increased risk of heart attack and stroke. The following dosage information applies to when the drug was available in the US.